ArticleECS sensors plus2025
Catheter-Electrode System for Continuous Aptamer-Based Sensing in the Rat Subcutaneous Space.
Article in ECS sensors plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrochemical aptamer-based (E-AB) sensors can continuously monitor drug concentrations with high temporal resolution. While previous studies have successfully demonstrated in vivo molecular monitoring using E-AB sensors, they typically rely on custom-built probes fabricated through manual, labor-intensive processes. Constructing such probes requires substantial time, technical expertise, and precision, creating a high barrier to entry for researchers interested in the field of in vivo measurements. To address this limitation, we present an alternative fabrication approach that combines established device construction methods with rapid prototyping via additive manufacturing (i.e., stereolithography). This platform enables continuous molecular monitoring in the subcutaneous interstitial fluid (ISF) of rodent models. We selected ISF as a target fluid due to its growing recognition as a promising frontier for continuous molecular monitoring and its central role in current biosensor research. Our goal is to eliminate the most prohibitive steps in traditional fabrication, thereby reducing the skill threshold required for building functional E-AB probes. By improving the construction process, our methods should make the technology more easily adoptable by a broader range of research laboratories. Ultimately, we aim to broaden the use of E-AB sensors and accelerate development in the field of real-time, in vivo molecular monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.